{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:34:29Z","timestamp":1787758469954,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.4103\/aian.aian_471_22","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T07:35:30Z","timestamp":1668843330000},"page":"1225-1227","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["New Onset Visual Loss in MOG Antibody Disease"],"prefix":"10.4103","volume":"25","author":[{"given":"Joe","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarath","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-58-20240828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0040-1701371","article-title":"Clinical course, imaging characteristics, and therapeutic response in myelin oligodendrocyte glycoprotein antibody disease: A case series","volume":"11","author":"James","year":"2020","journal-title":"J Neurosci Rural Pract"},{"key":"R2-58-20240828","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0b013e3283459826","article-title":"Review and update of central serous chorioretinopathy","volume":"22","author":"Ross","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-58-20240828","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: A review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R4-58-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2017.06.008","article-title":"Central serous chorioretinopathy and glucocorticoids: An update on evidence for association","volume":"63","author":"Nicholson","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R5-58-20240828","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/IAE.0000000000000159","article-title":"Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A population-based study in Taiwan","volume":"34","author":"Tsai","year":"2014","journal-title":"Retina"},{"key":"R6-58-20240828","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: An update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye"},{"key":"R7-58-20240828","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.ophtha.2004.03.025","article-title":"Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy","volume":"111","author":"Sharma","year":"2004","journal-title":"Ophthalmology"},{"key":"R8-58-20240828","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjophthalmol-2017-311096","article-title":"Spironolactone versus observation in the treatment of acute central serous chorioretinopathy","volume":"102","author":"Sun","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R9-58-20240828","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/IAE.0000000000001913","article-title":"Comparison of short-term efficacy between oral spironolactone treatment and photodynamic therapy for the treatment of nonresolving central serous chorioretinopathy","volume":"39","author":"Lee","year":"2019","journal-title":"Retina"},{"key":"R10-58-20240828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000324599","article-title":"Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy","volume":"46","author":"Fok","year":"2011","journal-title":"Ophthalmic Res"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_471_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:15:42Z","timestamp":1787757342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_471_22"}},"subtitle":["Optic Neuritis or Central Serous Retinopathy?"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_471_22","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}